Hugh Strickland speaks about his experience of hearing loss and his hopes for future treatments.
Hearing research
On 2 September, we proudly hosted the 2023 Hearing Therapeutics Summit, in collaboration with University College London’s Ear Institute, and the UCLH National Institute of Health Research at University College London Hospital.
A new cell therapy that could repair damage to the auditory nerve and improve hearing could hold fresh hope for people living with hearing loss.
A new drug proven to lower the risk of hearing loss in children with cancer by up to 42% awaiting approval in the UK.
The first medication to prevent hearing loss, caused by commonly used antibiotics, has been developed by biotechnology company, Oricula Therapeutics.
RNID is delighted to join forces with the University College London to run the 2023 Hearing Therapeutics Summit this Septem
RNID funded research from The University of Manchester shows that hearing loss is unlikely to be a common symptom of Covid-19.
Our Innovation Seed Fund provides small grants to researchers to enable them to investigate new ideas about the causes, treatment and diagnosis of hearing loss, tinnitus, and other hearing-related conditions.
RNID, and especially those of us in the Research team, are extremely saddened to hear of the death of Dr Christian Füllgrabe.
Cameron has Norrie Disease, a condition that means he was born blind. Now, at 10 years old, he's almost entirely lost his hearing, too. Fearing a life of silent darkness for her child, his mother Carla tells their story.